As of June 30, 2026, Eurocell Plc carries a market capitalization of 10.90B, placing it among publicly traded companies globally. Its enterprise value stands at 20.26B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10.90B |
| Enterprise Value | 20.26B |
Eurocell Plc's next confirmed earnings release is scheduled for March 25, 2027.
| Earnings Date | 3/25/2027 |
As of June 30, 2026, Eurocell Plc has 99.12M shares outstanding.
| Shares Outstanding | 99.12M |
These figures are as of June 30, 2026.
| PB Ratio | 1.11 |
| P/TBV Ratio | 1.90 |
As of June 30, 2026, Eurocell Plc maintains a current ratio of 1.42, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.42 |
| Quick Ratio | 0.08 |
| Debt / Equity | 102.85 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 2,301.00 |
As of the close on October 22, 2026, Eurocell Plc's stock has gained approximately 17.00% over the past 52 weeks. The 50-day moving average sits at 131.36, while the 200-day moving average is 119.35.
| 52-Week Price Change | 17.00% |
| 50-Day Moving Average | 131.36 |
| 200-Day Moving Average | 119.35 |
As of June 30, 2026, Eurocell Plc holds 760.00M in cash and equivalents against 10.12B in total debt, resulting in a net debt position of 2.80B. Total book value stands at 9.84B, with working capital of 3.92B providing operational flexibility.
| Cash & Cash Equivalents | 760.00M |
| Total Debt | 10.12B |
| Net Debt | 2.80B |
| Equity (Book Value) | 9.84B |
| Book Value Per Share | 99.27 |
| Working Capital | 3.92B |
Already premium?